nas been working on a new medication to a ent that it will likely be several more before s compared to the recent development of the he same funding incentives from the governı nich means it takes longer to manage the risk:
nas been working on a new medication to a ent that it will likely be several more before s compared to the recent development of the he same funding incentives from the governı nich means it takes longer to manage the risk:
Related questions
Question
Transcribed Image Text:Read the scenario below, and then respond to all three prompts (A, B, C) following the scenario.
Scenario
X Factor Pharma has been working on a new medication to address juvenile diabetes for several years, but just
released a statement that it will likely be several more before the drug makes it to market. When asked about
the slow progress compared to the recent development of the Covid19 vaccine, X Factor Pharma CEO stated
"We don't have the same funding incentives from the government, nor the support for research and
development, which means it takes longer to manage the risks on our end as we develop the treatment. Then,
we have to go through the rigorous processes required by the FDA to make it to market. We want to be sure we
have a product that will succeed, and that all takes time and money."
A. Describe the role that bureaucracy plays in the scenario above.
B. Explain how Congress could act to impact the scenario above.
C. The Pediatric Academy to End Juvenile Diabetes is an association of medical professionals across the country.
Explain how they could act to impact the scenario above.
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
Step by step
Solved in 3 steps
